Articles in Scholarly Journals [Incomplete List]

1. N-terminal Atrial Natriuretic Peptide Immunoreactivity in Plasma of Cats with Hypertrophic Cardiomyopathy
   Journal of Veterinary Internal Medicine, vol. 20, no. 2, p. 284, 2006
2. Endostatin and Vascular Endothelial Growth Factor Concentrations in Healthy Dogs, Dogs with Selected Neoplasia, and Dogs with Nonneoplastic Diseases
   Journal of Veterinary Internal Medicine, vol. 20, no. 1, p. 144, 2006
3. Fluid flow stimulates expression of osteopontin and bone sialoprotein by bone marrow stromal cells in a temporally dependent manner
   Bone, vol. 36, no. 6, pp. 1047–1055, 2005
4. Journal of Medicinal Chemistry, vol. 47, no. 25, pp. 6363–6372, 2004
5. Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor
   Journal of Cellular Biochemistry, vol. 93, no. 1, pp. 120–132, 2004
6. Complexity, fractals, disease time, and cancer
   Physical Review E, vol. 70, no. 6, 2004
7. Discovery and evaluation of 3-(5-Thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors
   Bioorganic & Medicinal Chemistry Letters, vol. 13, no. 18, pp. 2973–2976, 2003
8. Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR
   Bioorganic & Medicinal Chemistry Letters, vol. 13, no. 15, pp. 2485–2488, 2003
9. Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells
   Journal of Cellular Biochemistry, vol. 90, no. 1, pp. 13–22, 2003
10. Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics
    Bioorganic & Medicinal Chemistry Letters, vol. 12, no. 24, pp. 3537–3541, 2002
11. Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5-a]pyrimidines: A New Class of KDR Kinase Inhibitors
    Bioorganic & Medicinal Chemistry Letters, vol. 12, no. 19, pp. 2767–2770, 2002
12. Characterization and Quantitation of Phospholamban and Its Phosphorylation State Using Antibodies
    Biochemical and Biophysical Research Communications, vol. 267, no. 1, pp. 40–48, 2000
13. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate
    Proceedings of the National Academy of Sciences, vol. 95, no. 15, pp. 8795–8800, 1998
14. Angiotensin II Activates at Least Two Tyrosine Kinases in Rat Liver Epithelial Cells
    Journal of Biological Chemistry, vol. 270, no. 47, pp. 28440–28447, 1995
15. Biochemistry, vol. 33, no. 6, pp. 1518–1525, 1994
16. Regulation of cell proliferation and growth by angiotensin II
    Progress in Growth Factor Research, vol. 5, no. 2, pp. 177–194, 1994
17. Calcium-Dependent Increase in Tyrosine Kinase Activity Stimulated by Angiotensin II
    Proceedings of the National Academy of Sciences, vol. 89, no. 18, pp. 8837–8841, 1992
18. The molecular basis of gonadotropin-releasing hormone (GnRH) action in the pituitary gonadotrope
    Biology of Reproduction, vol. 36, no. 1, pp. 17–35, 1987
19. Mechanism of Action of Gonadotropin Releasing Hormone
    Annual Review of Physiology, vol. 48, no. 1, pp. 495–513, 1986
20. Increase in glucuronide conjugation of aflatoxin P1 after pretreatment with microsomal enzyme inducers
    Toxicology, vol. 32, no. 2, pp. 145–152, 1984
21. Purification and properties of carnitine acetyltransferases from bovine spermatozoa and heart
    Archives of Biochemistry and Biophysics, vol. 226, no. 1, pp. 94–110, 1983
22. Identification and hormonal control of reproductive-tract-specific antigens present in rabbit oviductal fluid
    Gamete Research, vol. 3, no. 2, pp. 169–177, 1980